Trial intelligence / Profile preview

Repetitive blood donations and endurance sport performance: effect of iron supplementation on hematological parameters

2017-003406-40Phase 4Completed

Sponsor
UCLouvain
Start
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Ferrous gluconate in iron deficiency anemia (IDA) (2 arms), sponsored by UCLouvain. Primary endpoint: VO2 max. Started Aug 2017; status: completed.

02

Drugs

Ferrous gluconate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on 2017-003406-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003406-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call